Status:
COMPLETED
Continuous Positive Airway Pressure for the Treatment of Stroke
Lead Sponsor:
Yale University
Conditions:
Acute Ischemic Stroke
Sleep Apnea
Eligibility:
All Genders
50+ years
Phase:
PHASE2
Brief Summary
New stroke therapies are needed. This study seeks to provide the preliminary data needed to plan a future study that will evaluate the efficacy of using continuous positive airway pressure (CPAP) to t...
Detailed Description
BACKGROUND Sleep apnea occurs in 60-96% of stroke survivors and is associated with poor functional recovery and higher post-stroke mortality. Among patients without stroke, continuous positive airway ...
Eligibility Criteria
Inclusion
- acute ischemic stroke with NIH Stroke Scale \>=2 -
Exclusion
- respiratory distress; COPD requiring oxygen; primary intracranial hemorrhage on admission brain imaging; time from symptom onset to sleep study or CPAP treatment \>72 hours or time from hospital admission to sleep study or CPAP treatment \>48 hours; life expectancy less than 6 months; inability to provide informed consent; inability to communicate in English; residence outside the greater New Haven area; or any condition where the monitoring required by the study would constitute a risk to the patient or impair his or her care.
- \-
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT00368628
Start Date
November 1 2004
End Date
March 1 2008
Last Update
March 3 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale-New Haven Hospital
New Haven, Connecticut, United States, 06520